Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 85,331 | 91,008 | 106,340 | 97,948 | 130,581 |
| Cost of Goods | 42,788 | 46,125 | 55,890 | 60,897 | 61,208 |
| Gross Profit | 42,543 | 44,883 | 50,450 | 37,051 | 69,373 |
| Operating Expenses | 153,580 | 172,493 | 127,940 | 154,153 | 137,040 |
| Operating Income | -110,249 | -127,485 | -76,600 | -116,205 | -67,459 |
| Interest Expense | 26 | 3,316 | 4,567 | 4,331 | 3,823 |
| Other Income | 13,573 | 40,404 | 6,963 | -72,392 | 7,622 |
| Pre-tax Income | -96,702 | -90,397 | -74,204 | -192,928 | -63,660 |
| Income Tax | -37,876 | 542 | 452 | -2,830 | -4,423 |
| Net Income Continuous | -58,826 | -90,939 | -74,656 | -190,098 | -59,237 |
| Net Income Discontinuous | -16,070 | -47,946 | N/A | N/A | N/A |
| Net Income | $-74,896 | $-138,885 | $-74,656 | $-190,098 | $-59,237 |
| EPS Basic Total Ops | -0.20 | -0.52 | -0.94 | -2.43 | -0.78 |
| EPS Basic Continuous Ops | -0.15 | -0.39 | -0.94 | -2.43 | -0.78 |
| EPS Basic Discontinuous Ops | -0.04 | -0.14 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.20 | -0.52 | -0.94 | -2.43 | -0.78 |
| EPS Diluted Continuous Ops | -0.15 | -0.39 | -0.94 | -2.43 | -0.78 |
| EPS Diluted Discontinuous Ops | -0.04 | -0.14 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.43 | -0.58 | -1.23 | -0.56 |
| EBITDA(a) | $-101,916 | $-118,059 | $-62,681 | $-101,852 | $-51,264 |